Literature DB >> 12209488

Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores.

Graciela S Alarcón1, Gerald McGwin, Kemi Brooks, Jeffrey M Roseman, Barri J Fessler, Martha L Sanchez, Holly M Bastian, Alan W Friedman, Bruce A Baethge, John D Reveille.   

Abstract

OBJECTIVE: To compare patient's and physician's assessment of disease activity in a multiethnic (Hispanic, African American, and Caucasian) cohort of systemic lupus erythematosus (SLE) patients.
METHODS: Three hundred patients with SLE from the LUMINA (Lupus in Minority populations: Nature versus nurture) cohort were included. Disease activity was assessed with the Systemic Lupus Activity Measure (SLAM); patients and physicians assessed disease activity using a 10-cm anchored visual analog scale (VAS). The difference between VAS scores was termed discrepancy (>1 cm was considered a priori clinically relevant). Selected sociodemographic, clinical, behavioral, and psychological variables were examined in relation to discrepancy in univariable and multivariable models adjusting for the physician global VAS score in order to eliminate ceiling and floor effects.
RESULTS: A discrepancy was exhibited by 58% of the patients. Abnormal laboratory findings were negatively associated with discrepancy, and poor self-perceived functioning and joint involvement were positively associated with discrepancy. Ethnicity did not account for discrepant perception of disease activity.
CONCLUSION: Patients and physicians rate disease activity in SLE differently. Physicians appear to place more emphasis on laboratory features while patients place more emphasis on function.

Entities:  

Mesh:

Year:  2002        PMID: 12209488     DOI: 10.1002/art.10512

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

Review 1.  Treatment of lupus: impact on quality of life.

Authors:  Sergio M A Toloza; Winston Sequeira; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

2.  Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.

Authors:  Jennifer L Barton; John Imboden; Jonathan Graf; David Glidden; Edward H Yelin; Dean Schillinger
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

Review 3.  Ethnic disparities in patients with systemic lupus erythematosus.

Authors:  América G Uribe; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 4.  Non-pharmacologic therapies for systemic lupus erythematosus.

Authors:  M Fangtham; S Kasturi; R R Bannuru; J L Nash; C Wang
Journal:  Lupus       Date:  2019-04-08       Impact factor: 2.911

5.  Level of patient-physician agreement in assessment of change following conservative rehabilitation for shoulder pain.

Authors:  Stephanie D Moore-Reed; W Ben Kibler; Heather Bush; Tim L Uhl
Journal:  Shoulder Elbow       Date:  2016-07-15

6.  Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity.

Authors:  Nasim A Khan; Horace J Spencer; Esam Abda; Amita Aggarwal; Rieke Alten; Codrina Ancuta; Daina Andersone; Martin Bergman; Jurgen Craig-Muller; Jacqueline Detert; Lia Georgescu; Laure Gossec; Hisham Hamoud; Johannes W G Jacobs; Ieda Maria Magalhaes Laurindo; Maria Majdan; Antonio Naranjo; Sapan Pandya; Christof Pohl; Georg Schett; Zahraa I Selim; Sergio Toloza; Hisahi Yamanaka; Tuulikki Sokka
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-02       Impact factor: 4.794

Review 7.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

8.  Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Authors:  X Ng; S dosReis; R Beardsley; L Magder; C D Mullins; M Petri
Journal:  Lupus       Date:  2017-08-31       Impact factor: 2.911

9.  Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico.

Authors:  América G Uribe; Juanita Romero-Díaz; Mandar Apte; Mónica Fernández; Paula I Burgos; John D Reveille; Jorge Sánchez-Guerrero; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-08-28       Impact factor: 7.580

10.  Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus.

Authors:  A M Eudy; A I Vines; M A Dooley; G S Cooper; C G Parks
Journal:  Lupus       Date:  2014-07-23       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.